Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Nature Communications|June 16, 2021
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL proteaseHaixia Su, Sheng Yao, Wenfeng Zhao, et al.Nature Structural & Molecular Biology|March 6, 2021
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suraminWanchao Yin, Xiaodong Luan, Zhihai Li, et al.Journal of Medicinal Chemistry|April 28, 2025
Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSVYong Cheng, Wei Zheng, Xinru Dong, et al.Cell Chemical Biology|November 20, 2024
Host specific sphingomyelin is critical for replication of diverse RNA virusesShuo Han, Xiaolei Ye, Jintong Yang, et al.Nature Structural & Molecular Biology|May 9, 2020
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofurZhenming Jin, Yao Zhao, Yuan Sun, et al.Nature Communications|October 13, 2023
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvirXiangrui Jiang, Haixia Su, Weijuan Shang, et al.Cell Discovery|January 7, 2023
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2Bingqing Xia, Xiaoyan Pan, Rong-Hua Luo, et al.Protein & Cell|August 6, 2020
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Rui Xiong, Leike Zhang, Shiliang Li, et al.Protein & Cell|April 17, 2021
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitorsYao Zhao, Xiaoyu Du, Yinkai Duan, et al.Virologica Sinica|September 10, 2020
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In VitroLeike Zhang, Jia Liu, Ruiyuan Cao, et al.Pageof 14